For children with hemophilia, every new research advance is a step toward a life filled with more activity, freedom, and adventure. The genetic condition, which affects roughly one in 5,000 births, causes children to bleed and bruise more easily than others ‚Äì meaning that a simple cut, scrape, or small surgery can result in uncontrollable and excessive bleeding. While hemophilia
This week's In the News highlights remind us of one of our favorite quotes from Helen Keller: "Alone we can do so little; together we can do so much." Read on to see how researchers from Children's Hospital of Philadelphia are working with different groups who share the same vision and scientific goals to advance pediatric care.
The Cancer Pharmacology Laboratory supports clinical trials of new mechanistically targeted and immune-based anticancer drugs by conducting pre-clinical and clinical pharmacology studies of the agents. The lab also studies conventional anticancer drugs to develop more rational and effective dosing methods, and the lab team is developing circulating biomarkers of organ function, drug toxicity, and tumor burden as clinical trial endpoints.